This measure is to be submitted a minimum of once per performance period for patients with diabetes seen during the performance period. CGM systems consist of a sensor, transmitter and receiver. 3392 e11. AND Patient encounter during the performance period (CPT): 66840, 66850, 66852, 66920, 66930, 66940, 66982, 66983, 66984 WITHOUT Modifier: 56 or 55 AND NOT DENOMINATOR EXCLUSION: Any of the following significant ocular conditions that impact the visual outcome of surgeryMeasure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. 11*, E85. A distinct numeric result is required for numerator compliance. docx from Financial Management MISC at CDI College of Business, Technology and Health Care. E11. This revision has a retroactive effective date of 2/26/2018. Version 7. 3511 E11. 2020 Medicare Part B Claims Flow Narrative for Quality ID #1 NQF #0059: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) Disclaimer: 1HIGHMARK COMMERCIAL MEDICAL POLICY - PENNSYLVANIA . 2022 MIPS Measure #127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of FootwearAppend a modifier (1P or 2P) to CPT Category II code 5010F to report documented circumstances that appropriately exclude patients from the denominator. ICD-10-CM code E11. 40, E11. Medication Therapy Management Services (MTMS) for the purpose of this policy are defined as a individual-specific medication evaluation based on a Medicaid Expansion (ME) member's chronic diseases and current medication list. Initial authorization will be for a period of 12 months. 3393* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 1 of the Program Integrity Manual, to remove all coding from LCDs and incorporate into related Billing and Coding Articles. 3393 E10. Hypertension complicating pregnancy, childbirth, and the puerperium. , measurement of the ability to see points of light at varying locations on a curved surface. Cataract development occurs in 60% of adults 65 years of age or greater. 3293 became effective on October 1, 2023. 8 C79. It is the leading cause of blindness in adults between 20-74 years of age. 3399* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy. CGM systems consist of a sensor, transmitter and receiver. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema right eye E11. This will allow the postoperative period to occur within the reporting year. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. 0% and less than 8. 3399 With severe nonproliferative retinopathy, with macular edema E11. 3392 E11. 3543: bilateral Start Patients 18 to 75 years of age on date of encounter Not included in Eligible Population/Denominator No Yes Yes No No Patient encounter during the performance period E11. E11. Electroretinography used to diagnose loss of retinal function or distinguish between retinal lesions and optic nerve lesions may be considered medically necessary for ANY ONE of the following indications (This is not an all-inclusive list):. View E11. 3499 With proliferative retinopathy, with macular edema E11. Avacincaptad pegol intravitreal solution (Izervay) may be considered medically necessary for the treatment of individuals with the following condition: Geographic atrophy (GA) secondary to nonexudative (dry) AMD; and. 331 Internal Medical Policy Committee 3-23-2022 Annual Review-no changes in criteria. Significant Ocular Condition Corresponding ICD-10-CM Codes . 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3491 E11. 3 C56. Scanning computerized ophthalmic diagnostic imaging allows earlier detection of glaucoma and more sophisticated analysis for ongoing management. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3391 - E11. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. 3311 e11. 3312 E10. There are multiple factors associated with cataract development. 3519 e10. 3491 e11. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association [ADA], 2018). 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3592, e11. Acceptable Reasons for Exceeding the LCD Maximum. The following code(s) above E11. Abstract: Visual field testing detects defects in the field of vision, testing the function of the retina, optic nerve and optic pathways. 8E11. 22. 00 or G70. E11. A portable external infusion pump may be considered medically necessary when ALL of the following are met: It is used for the administration of medications; and. 3499 With proliferative retinopathy, with macular edema E11. It is the leading cause of blindness in adults between 20-74 years of age. Performance Not Met: Most recent hemoglobin A1c (HbA1c) level greater than or equal to 7. Miscellaneous central nervous system agents . 0% (3044F) OR. 3519. Type 2 diabetes mellitus with stable proliferative diabetic retinopathy. 3391 ☐ E11. Description. 3512 e11. People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney failure, amputation of toes, feet or legs, and premature death. 3112, h35. 10 became effective on October 1, 2023. Performance Met: Hemoglobin A1c level was not performed during the measurement period (12 months) (3046F with 8P) OR. E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. MTMS are to be completed by a MTMS pharmacist provider face-to-face and will include a complete assessment. e11. Clinicians who indicate modifier 55, postoperative management. 3393 [convert to ICD-9-CM] Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral. Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam by an eye care professional during the measurement period or diabetics with no diagnosis of retinopathy in any part of the measurement period who had a retinal or. Payment may be made for only one pump for administering the medications; and. E13. 3393. The following services are considered to be components of routine foot care, regardless of the provider rendering the service: Cutting or removal of corns and calluses; Clipping, trimming, or debridement of nails, including debridement of mycotic nails; Shaving, paring, cutting or removal of keratoma, tyloma, and heloma;eCQM #. At this time 21 st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. 3391 e10. 10 - R11. 3512 E11. This article is being revised in order to adhere to CMS requirements per chapter 13, section 13. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality. 3399 With severe nonproliferative retinopathy, with macular edema E11. Type 1 Excludes. Denominator Exception: Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy (eg, allergy, intolerance, pregnancy, renal☐ E11. 3511 e10. Under Associated Contractor Numbers added 11201, 11301, 11401, and 11501. E11. 3412 left eye E11. 3391 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema right eye E11. 33. E11. 3411 - E11. 3513. 3210. 3313 E10. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. This measure may be submitted by non-medical doctor/doctor of osteopathic medicine (MD/DO) Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. Scanning computerized ophthalmic diagnostic imaging allows earlier detection of glaucoma and more sophisticated analysis for ongoing management. 3393 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 3393* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 339 for Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema - Non-billable. E11. 29 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with other diabetic kidney complication. 3523 E11. E11. Toggle Menu. Continuous Glucose Monitoring (CGM) Systems (also known as Real-Time or interstitial) monitor, measure, and record glucose levels in interstitial fluid and produce. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the. 3391 - E11. 2007 PQRI SUMMARY. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema right eye E11. 3393 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral;E11. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. 22. Article Text. 3393: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye - Type 2 diabetes mellitus with moderate. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association, 2018). 3313: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral E11. 321, E09. E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 8 D27. E11. 20, H44. E11. 311 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 2019 Quality Measures 3 Diabetes: Eye Exam Eyefinity EHR Instructions Performance Met Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist E11. 3413 severe no e10. , triglycerides, LDL cholesterol), whether in a panel or separately ordered. The procedure is performed separately for each eye, and measures the combined function of the retina, the optic nerve, and the intracranial visual pathway. 331. 1 C56. Unlisted codes A4641, A9698, A9699, J1599, J3490, J3590, J7199, J9999, J7999, Q2039, and Q4100 billed to the Part B MAC are priced manually. 3511-E11. All rights reserved. It means "not coded here". 3591-E11. 37X3. Pay lesser of billed charges and cost invoice. No substantive changes were made to the active LCD. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E11. Continuous Glucose Monitoring (CGM) Systems (also known as Real-Time or interstitial) monitor, measure, and record glucose levels in interstitial fluid and produce data that show trends in glucose measurements. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Women-only measures Screening and care documentation guidelines Code(s) Cervical Cancer Screening (CCS) 21- to 64-year-old women Evidence of pap exam within last three yearsCoverage Indications, Limitations, and/or Medical Necessity. d Start Diagnosis for diabetes as listed in Denominator* Footwear evaluation performed and documented Footwear evaluation was not performed No Data Completeness Not MetThe 2024 edition of ICD-10-CM E11. 37X3. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. E11. 3 D09. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 1 of the Program Integrity Manual, to remove all coding from LCDs and incorporate into related Billing and Coding Articles. E11. ERG measures the electrical activity generated by neural and non-neuronal cells in the retina in response to a light stimulus. 3412 Methods. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3413: Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with. 3412 Type 2 diabetes mellitus with severe non-proliferative diabetic retinopathy with macular edema, left. Medication Therapy Management Services (MTMS) for the purpose of this policy are defined as a individual-specific medication evaluation based on a Medicaid Expansion (ME) member's chronic diseases and current medication list. S. 3130, h35. Glaucoma is a leading cause of blindness, and a disease for which treatment methods clearly are available and in common use. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3399 Type 2 diabetes mellitus with moderate nonpro. , 2015). 3491 e11. 3513 e10. E11. 3511. 1 result found: ICD-10-CM Diagnosis Code E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 37X2. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. E11. 3393 X E11. 3399 With severe nonproliferative retinopathy, with macular edema E11. 3493 e10. CMS 131v11. gov means it's official. See full list on icdlist. S. 3313 X E11. 3311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. Description. 3519. 2This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for Routine Foot Care. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3412 e11. 3391 E11. E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. Shoe trauma, in concert with loss of protective sensation and concomitant foot deformity, is the leading eventScanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. E11. 3393 Type 2 diabetes mellitus with moderate non-proliferative diabetic retinopathy without macular edema, bilateral; E11. 3412 e10. 3411 Type 2 diabetes mellitus with. E11. 3411 Type 2 diabetes mellitus with severe nonproli. In 2017, diabetes cost the U. E11. 3411 E11. Full field electroretinogram (ERG) is used to detect loss of retinal function or distinguish between retinal and optic nerve lesions. E11. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. QLLs that exceed the allowed amount of strips, lancet, and lens shield cartridges are covered when ALL of the following are met. 2, or R11. 3392 E10. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. Glaucoma is a leading cause of blindness, and a disease for which treatment methods clearly are available and in common use. *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). Visual fields are examined using static or kinetic perimetry. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3413 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edemaE11. Cataract development occurs in 60% of adults 65 years of age or greater. 3411 Type 2 diabetes mellitus with severe non-proliferative diabetic retinopathy with macular edema, right eye; E11. 3511 e11. This. 10 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Coverage Indications, Limitations, and/or Medical Necessity. E13. 339 became effective on October 1, 2023. Indications:Patients whose most recent HbA1c level (performed during the measurement period) is > 9. 82, E85. 3413 e11. E11. 3411 ☐ E11. 3313 e11. (CDC Fact Sheet 2014). 0 CPT only copyright 2020 American Medical Association. 10/10/2019. 0% (3051F) OR. CMS Measure ID: #488 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical Care Measure Age: New Instructions. E11. 3522 e10. Description Prescription Description. This was a coding algorithm development and comparison study; no patient selection or analysis of patient data was performed. 3313 X E11. 3391 E11. 0 D27. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. 43, E11. 3120, h35. E11. 3312 e11. DilatedThis site works best if viewed with the latest version of Internet Explorer, Firefox, Chrome, or Safari browsers. Continuous Glucose Monitoring (CGM) Systems (also known as Real-Time or interstitial) monitor, measure, and record glucose levels in interstitial fluid and produce. 3 D09. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Pegcetacoplan (SyfovreTM) is an intravitreal injection for the treatment of GA that works by slowing progression of GA lesions that can permanently damage the macula. The surgery involves excision of the lateral aspect of the stomach, leaving a much reduced, tubular stomach. 3411 E11. Use E11. health complications including vision loss, heart disease, stroke, kidney failure, amputation of toes, feet or legs, and premature death. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Page 4 of 6 Kidney Health Evaluation for Patients With Diabetes (KED) HEDIS definition This measure evaluates members 18 to 85 years of age with diabetes (type 1 and type 2) whoEffective April 1, 2023 through June 30, 2023. These non-covered services should be counted in theE11. 339. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure for the primary management of patients with CAD. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3313 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. A9274. It is the goal of these diagnostic imaging tests. 11 result found: ICD-10-CM Diagnosis Code E11. 3411 E11. This was a coding algorithm development and comparison study; no patient selection or analysis of patient data was performed. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 39 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with other diabetic ophthalmic complication. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3412 ☐. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3523 e10. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 83718. ICD-10-CM Diagnosis Code E11. Internal Medical Policy Committee 7-21-2022 Coding update - Effective September 05, 2022. 3519 E11. E13. E11. 3393 Diabetes with Severe NPDR with Macular Edema Type 2 Type 1 ☐ E11. 3313 free coding rules and guidelines,. 3311-E11. 331 Internal Medical Policy Committee 3-23-2022 Annual Review-no changes in criteria. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. E08. E11. RATIONALE: Foot ulceration is the most common single precursor to lower extremity amputations among persons with diabetes. 3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. , diabetes kills approximately 79,500 people a year (CDC Health 2017). Description Right Eye Left Eye Bilateral Unspecified; With macular edema and other specified diabetes. 9 D34 D35. Diabetic retinopathy is progressive damage to the small blood vessels in the retina that may result in loss of vision. 3393 E10. E11. Lipids: 80061. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Scanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. 3513, E11. Payment may be made for only one pump for administering the medications; and. It is the goal of these diagnostic imaging tests to discriminate among patients with normal intraocular pressures (IOP) who have glaucoma, patients with elevated IOP who have. This sensor operates using signal and low reference. 3492 e10. Cataract development occurs in 60% of adults 65 years of age or greater. Assuming the patient's primary diagnostic code is E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 33 is a non-billable ICD-10 code for Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy. 3393 bilateral E11. 99504, 99509, e0100, e0105, e0130, e0135, e0140, e0141, e0143, e0144, e0147, e0148, e0149, e0163, e0165, e0167, e0168, e0170, e0171, e0250, e0251, e0255, e0256,E11. Under Group 1: Codes added ICD-10 codes E11. Quality ID #19 (NQF 0089): Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care – National Quality Strategy Domain: Communication and Care Coordination – Meaningful Measure Area: Transfer of Health Information and Interoperability 2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS)E11. E11. Pancreas transplant alone may be considered medically necessary in individuals with severely disabling and potentially life-threatening complications due to hypoglycemia unawareness and labile insulin-dependent diabetes that persists despite optimal medical management. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD. They are not repeated. Payment may be made for only one pump for administering the medications; and. In 2017, diabetes cost the U. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Myopic Choroidal Neovascularization (mCNV); or. 3491 e10. Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema. E11. Other Contractor Local Coverage Determinations. Version 7. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3492 E11. 33 contain annotation back-references E11. E11. 593) CPT Codes Corneal graft procedure (CPT: 65756 with modifier RT, LT) How to Report the Measure This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association, 2018). 592, H18. Summary of Evidence. ICD-10-CM Diagnosis Code E11. S. This is a 41 percent increase from the estimated $174 billion spent on diabetes in 2007 (ADA EconomicGlaucoma is a leading cause of blindness, and a disease for which treatment methods clearly are available and in common use. 2This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for Routine Foot Care. The Part A Ophthalmology: Extended Ophthalmoscopy and Fundus Photography LCD L34571 is being retired effective 02/19/2016 as this LCD is being incorporated into LCD L33467. 3299 With moderate nonproliferative retinopathy, with macular edema E11. When performed laparoscopically, the term laparoscopic sleeve gastrectomy (LSG) is used. . 3493 e11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11.